Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Daisy Alapat

Concepts (227)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
21
2022
2686
1.600
 Why?
Flow Cytometry
5
2018
581
1.010
 Why?
Immunoglobulins
2
2018
84
0.850
 Why?
Immunoglobulin kappa-Chains
2
2016
31
0.770
 Why?
DNA, Neoplasm
1
2018
177
0.680
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2015
99
0.650
 Why?
Bone Marrow
6
2022
408
0.640
 Why?
Immunoglobulin lambda-Chains
1
2015
16
0.610
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2016
75
0.600
 Why?
Gene Rearrangement, B-Lymphocyte
1
2015
6
0.600
 Why?
Receptors, Antigen, B-Cell
1
2015
8
0.590
 Why?
Plasma Cells
2
2016
225
0.550
 Why?
Neoplasm, Residual
5
2022
172
0.530
 Why?
Hematopoietic Stem Cell Transplantation
3
2022
531
0.480
 Why?
Lymphoma, Mantle-Cell
1
2012
19
0.480
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2012
10
0.480
 Why?
Cell Differentiation
1
2015
750
0.450
 Why?
Carcinoembryonic Antigen
1
2011
15
0.450
 Why?
Calcitonin
1
2011
40
0.450
 Why?
Antigens, CD
1
2012
264
0.420
 Why?
Carcinoma
1
2011
152
0.400
 Why?
Myogenin
1
2008
6
0.390
 Why?
Muscle Fibers, Slow-Twitch
1
2008
11
0.390
 Why?
Muscle Fibers, Fast-Twitch
1
2008
13
0.390
 Why?
Humans
37
2022
50276
0.340
 Why?
Neoplasms, Second Primary
2
2019
72
0.330
 Why?
Middle Aged
16
2021
13149
0.290
 Why?
Gene Expression Profiling
3
2016
1082
0.290
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2021
1008
0.290
 Why?
Pancytopenia
3
2016
38
0.290
 Why?
Treatment Outcome
10
2022
5421
0.280
 Why?
Plasmacytoma
2
2020
43
0.240
 Why?
Neoplasms, Plasma Cell
2
2020
16
0.240
 Why?
Embolization, Therapeutic
2
2021
78
0.240
 Why?
Cryosurgery
1
2021
35
0.230
 Why?
Prognosis
5
2021
2057
0.210
 Why?
Skin Neoplasms
2
2016
532
0.200
 Why?
Female
18
2021
27910
0.200
 Why?
Tumor Microenvironment
1
2020
137
0.200
 Why?
Male
15
2021
27231
0.200
 Why?
Aged
14
2021
10017
0.200
 Why?
Combined Modality Therapy
1
2021
701
0.190
 Why?
Ploidies
1
2018
13
0.180
 Why?
Leukemia, Myeloid, Acute
1
2019
176
0.180
 Why?
Herpesvirus 8, Human
1
2019
78
0.180
 Why?
Hematopoietic Stem Cells
1
2019
232
0.170
 Why?
Sarcoma, Myeloid
1
2017
23
0.170
 Why?
Chromosomes, Human, Pair 17
1
2017
45
0.170
 Why?
Kidney Diseases
1
2020
279
0.170
 Why?
Amyloidosis
2
2016
81
0.160
 Why?
CA-125 Antigen
1
2016
20
0.160
 Why?
Lymph Nodes
2
2019
287
0.160
 Why?
Immunohistochemistry
3
2016
1129
0.160
 Why?
Chromosome Deletion
1
2017
146
0.160
 Why?
Skin Diseases, Infectious
1
2016
8
0.160
 Why?
Leukemia, Promyelocytic, Acute
1
2016
11
0.160
 Why?
Cell Cycle
1
2018
270
0.160
 Why?
Anemia, Aplastic
1
2016
13
0.160
 Why?
Myeloproliferative Disorders
1
2016
25
0.160
 Why?
Monoclonal Gammopathy of Undetermined Significance
1
2016
77
0.150
 Why?
Electrophoresis, Capillary
1
2015
14
0.150
 Why?
Transplantation, Autologous
3
2022
459
0.150
 Why?
In Situ Hybridization
1
2015
87
0.150
 Why?
V(D)J Recombination
1
2015
4
0.150
 Why?
Tumor Suppressor Protein p53
1
2017
254
0.150
 Why?
Immunophenotyping
1
2015
128
0.150
 Why?
Fatal Outcome
1
2015
231
0.140
 Why?
RNA, Messenger
2
2015
1239
0.140
 Why?
Immunoglobulin Light Chains
1
2015
97
0.140
 Why?
Prealbumin
1
2014
25
0.140
 Why?
Diagnosis, Differential
3
2016
1151
0.140
 Why?
Bone Marrow Neoplasms
1
2014
15
0.140
 Why?
Bone Marrow Transplantation
2
2022
165
0.140
 Why?
Hodgkin Disease
1
2014
49
0.130
 Why?
Neoplasm Proteins
1
2016
379
0.130
 Why?
Parvoviridae Infections
1
2013
20
0.130
 Why?
Parvovirus B19, Human
1
2013
17
0.130
 Why?
Partial Thromboplastin Time
1
2012
12
0.130
 Why?
Prothrombin Time
1
2012
20
0.130
 Why?
Polymerase Chain Reaction
1
2015
532
0.130
 Why?
Cardiomyopathies
1
2014
110
0.130
 Why?
Afibrinogenemia
1
2012
5
0.130
 Why?
Immunoglobulins, Intravenous
1
2013
56
0.130
 Why?
Retroperitoneal Neoplasms
1
2012
23
0.120
 Why?
Paraproteinemias
1
2012
66
0.120
 Why?
Glycoproteins
1
2012
135
0.120
 Why?
Plasma Exchange
1
2012
33
0.120
 Why?
Precursor Cells, B-Lymphoid
1
2012
9
0.120
 Why?
Predictive Value of Tests
1
2015
1044
0.120
 Why?
Phenotype
1
2015
801
0.120
 Why?
Histoplasma
1
2011
27
0.120
 Why?
Antigens, Fungal
1
2011
30
0.110
 Why?
Gene Expression Regulation, Neoplastic
1
2016
878
0.110
 Why?
Immunoenzyme Techniques
1
2011
173
0.110
 Why?
Hepatitis C
1
2012
92
0.110
 Why?
Histoplasmosis
1
2011
53
0.110
 Why?
Carcinoma, Neuroendocrine
1
2011
28
0.110
 Why?
Splenic Neoplasms
1
2009
3
0.100
 Why?
Adult
7
2021
13861
0.100
 Why?
Dose-Response Relationship, Drug
2
2016
1550
0.100
 Why?
Myelodysplastic Syndromes
1
2009
83
0.100
 Why?
Mutagenesis, Site-Directed
1
2008
114
0.090
 Why?
Hemangioma
1
2009
79
0.090
 Why?
Thyroid Neoplasms
1
2011
152
0.090
 Why?
Gene Expression
1
2012
701
0.090
 Why?
HIV Infections
1
2012
378
0.090
 Why?
Protein Processing, Post-Translational
1
2008
178
0.090
 Why?
Aged, 80 and over
4
2019
3496
0.090
 Why?
Survival Analysis
2
2021
787
0.080
 Why?
Stem Cell Transplantation
2
2022
195
0.080
 Why?
Graft vs Host Disease
1
2007
83
0.080
 Why?
Cells, Cultured
2
2008
1787
0.080
 Why?
Positron-Emission Tomography
2
2021
311
0.080
 Why?
Muscle Proteins
1
2008
308
0.080
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2005
39
0.080
 Why?
Semaphorin-3A
1
2004
2
0.070
 Why?
Acid Anhydride Hydrolases
1
2004
16
0.070
 Why?
Nerve Degeneration
1
2004
38
0.070
 Why?
p38 Mitogen-Activated Protein Kinases
1
2005
101
0.070
 Why?
Mitogen-Activated Protein Kinase 3
1
2004
55
0.070
 Why?
Mitogen-Activated Protein Kinase 1
1
2004
57
0.070
 Why?
Antineoplastic Agents
1
2013
1244
0.070
 Why?
Pyridines
1
2005
138
0.070
 Why?
Imidazoles
1
2005
149
0.070
 Why?
Muscle, Smooth, Vascular
1
2005
155
0.070
 Why?
Pyrimidines
1
2005
188
0.070
 Why?
Gene Expression Regulation
1
2008
1117
0.060
 Why?
Hippocampus
1
2004
242
0.060
 Why?
Enzyme Inhibitors
1
2005
439
0.060
 Why?
Cohort Studies
2
2020
1444
0.060
 Why?
Case-Control Studies
2
2019
1224
0.060
 Why?
Mediastinum
1
2021
25
0.060
 Why?
Vincristine
1
2021
94
0.060
 Why?
Axilla
1
2021
96
0.060
 Why?
Prednisone
1
2021
115
0.060
 Why?
Pelvis
1
2021
74
0.060
 Why?
Alzheimer Disease
1
2004
300
0.050
 Why?
Cyclophosphamide
1
2021
190
0.050
 Why?
Fluorodeoxyglucose F18
1
2021
199
0.050
 Why?
Neurons
1
2004
476
0.050
 Why?
Tumor Burden
1
2020
142
0.050
 Why?
Radiopharmaceuticals
1
2021
252
0.050
 Why?
Disease Progression
2
2016
867
0.050
 Why?
Signal Transduction
2
2004
1801
0.050
 Why?
False Negative Reactions
1
2019
38
0.050
 Why?
Herpesvirus 4, Human
1
2019
40
0.050
 Why?
Doxorubicin
1
2021
264
0.050
 Why?
Virus Diseases
1
2019
30
0.050
 Why?
Epstein-Barr Virus Infections
1
2019
35
0.050
 Why?
Time Factors
2
2017
3352
0.050
 Why?
Herpesviridae Infections
1
2019
47
0.050
 Why?
In Situ Hybridization, Fluorescence
2
2014
273
0.050
 Why?
Genome, Viral
1
2019
88
0.050
 Why?
Phosphorylation
3
2005
620
0.050
 Why?
Adolescent
1
2011
6596
0.050
 Why?
DNA, Viral
1
2019
151
0.050
 Why?
Neoplasm Recurrence, Local
1
2022
576
0.040
 Why?
Tomography, X-Ray Computed
2
2014
1235
0.040
 Why?
Retrospective Studies
2
2019
5676
0.040
 Why?
Scleromyxedema
1
2016
5
0.040
 Why?
Schnitzler Syndrome
1
2016
4
0.040
 Why?
Xanthomatosis
1
2016
9
0.040
 Why?
Cryoglobulinemia
1
2016
12
0.040
 Why?
Asymptomatic Diseases
1
2016
41
0.040
 Why?
POEMS Syndrome
1
2016
32
0.040
 Why?
Melphalan
1
2016
176
0.040
 Why?
Disease-Free Survival
1
2016
520
0.040
 Why?
Reed-Sternberg Cells
1
2014
2
0.040
 Why?
HIV Seronegativity
1
2014
3
0.040
 Why?
Karyotype
1
2014
19
0.040
 Why?
Fusion Proteins, bcr-abl
1
2014
22
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2015
217
0.030
 Why?
Heterozygote
1
2014
84
0.030
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2014
48
0.030
 Why?
Thalidomide
1
2016
405
0.030
 Why?
Cell Division
2
2005
366
0.030
 Why?
Remission Induction
1
2014
217
0.030
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
699
0.030
 Why?
Oligonucleotide Array Sequence Analysis
1
2015
477
0.030
 Why?
Mutation
1
2019
1361
0.030
 Why?
Fibrinogen
1
2012
46
0.030
 Why?
Blood Coagulation
1
2012
78
0.030
 Why?
Neoplasm Staging
1
2015
792
0.030
 Why?
Reference Values
1
2012
382
0.030
 Why?
Survival Rate
1
2015
995
0.030
 Why?
Mycological Typing Techniques
1
2011
2
0.030
 Why?
Antibodies, Fungal
1
2011
4
0.030
 Why?
Cross Reactions
1
2011
55
0.030
 Why?
Risk Assessment
1
2017
1387
0.030
 Why?
Lung Diseases, Fungal
1
2011
33
0.030
 Why?
Biopsy
1
2014
686
0.030
 Why?
Immunocompromised Host
1
2011
130
0.030
 Why?
Splenectomy
1
2009
37
0.030
 Why?
Severity of Illness Index
1
2012
1063
0.020
 Why?
Sensitivity and Specificity
1
2011
953
0.020
 Why?
Blood Transfusion
1
2009
123
0.020
 Why?
Transplantation, Isogeneic
1
2007
4
0.020
 Why?
Laparoscopy
1
2009
168
0.020
 Why?
Mice, Inbred C3H
1
2007
85
0.020
 Why?
Cyclosporine
1
2007
67
0.020
 Why?
Mice, SCID
1
2007
199
0.020
 Why?
Models, Animal
1
2007
266
0.020
 Why?
Magnetic Resonance Imaging
1
2014
1592
0.020
 Why?
Immunosuppressive Agents
1
2007
251
0.020
 Why?
Macromolecular Substances
1
2004
47
0.020
 Why?
Physical Chromosome Mapping
1
2004
10
0.020
 Why?
tau Proteins
1
2004
27
0.020
 Why?
Genetic Complementation Test
1
2004
50
0.020
 Why?
Mice
2
2007
6232
0.020
 Why?
Catalytic Domain
1
2004
56
0.020
 Why?
Cricetulus
1
2004
101
0.020
 Why?
Epidermal Growth Factor
1
2004
45
0.020
 Why?
Epitopes
1
2004
84
0.020
 Why?
Microtubule-Associated Proteins
1
2004
79
0.020
 Why?
Mutagenesis
1
2004
73
0.020
 Why?
Cloning, Molecular
1
2004
205
0.020
 Why?
Cricetinae
1
2004
205
0.020
 Why?
Intercellular Signaling Peptides and Proteins
1
2004
133
0.020
 Why?
Receptors, Cell Surface
1
2004
137
0.020
 Why?
RNA
1
2004
175
0.020
 Why?
Amino Acid Sequence
1
2004
759
0.020
 Why?
Cell Survival
1
2005
680
0.020
 Why?
Nerve Tissue Proteins
1
2004
214
0.020
 Why?
Molecular Sequence Data
1
2004
970
0.020
 Why?
Mice, Inbred C57BL
1
2007
2022
0.010
 Why?
Cell Line
1
2004
1205
0.010
 Why?
Animals
2
2007
14247
0.010
 Why?
Alapat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (227) concept(s)
_
Co-Authors Expand Description
See all (38) people
_
Similar People Expand Description
See all (26) people
_
Same Department Expand Description
Search Department